genesis.ml logo

genesis.ml

Revenue
$25M - $35M

genesis.ml Revenue and Company Metrics

Estimated Annual Revenue
$25M - $35M

Estimate based on public data analysis. Genesis is a leader in generative AI for drug discovery, de-risking the historically difficult process of finding novel medicines through a proprietary, physics-informed AI platform that has already secured significant commercial validation from major pharmaceutical partners.

genesis.ml Competitors by Market Segment

Top Rung: The Publicly Acclaimed Innovator
Google DeepMind / Isomorphic Labs (AlphaFold)
Established Incumbent: The Trusted Industry Standard
Schrödinger
The Performance Challenger (Genesis's Position)
Genesis Molecular AI
The Crowded Field: The AI-Powered Contenders
Recursion Pharmaceuticals Exscientia Insitro AbCellera

Competitive landscape based on market segment analysis and industry data.

Company Analysis Tool

Analyze market position, revenue estimates, and competitive landscape for any company

Analyze a Company

2-3 minutes • No credit card required • Instant results

Frequently Asked Questions

What is genesis.ml's estimated revenue?

Based on our analysis of public data, genesis.ml's estimated revenue is approximately $25M - $35M.

Who are genesis.ml's competitors?

Based on market analysis, genesis.ml competes with Google DeepMind / Isomorphic Labs (AlphaFold), Schrödinger, Genesis Molecular AI, Recursion Pharmaceuticals, and Exscientia , and others. See the competitive landscape section above for a complete breakdown by market segment.

How much does genesis.ml cost?

Pricing is not publicly available; the business model is based on high-value enterprise partnerships and collaborations, not self-serve plans.